The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(5-(1-methyl-1H-indazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-2,7-diazaspiro[3.5]nonan-1-one ID: ALA4878356
PubChem CID: 156409245
Max Phase: Preclinical
Molecular Formula: C22H22N6O
Molecular Weight: 386.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CC3)CNC4=O)ccc21
Standard InChI: InChI=1S/C22H22N6O/c1-27-18-3-2-14(10-15(18)11-26-27)17-12-24-20-16(4-7-23-20)19(17)28-8-5-22(6-9-28)13-25-21(22)29/h2-4,7,10-12H,5-6,8-9,13H2,1H3,(H,23,24)(H,25,29)
Standard InChI Key: ZDQFWXPJQYVSMT-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 34 0 0 0 0 0 0 0 0999 V2000
14.2780 -12.0268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7066 -12.6121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1213 -12.0365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6969 -11.4554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9871 -11.0512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9773 -10.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6856 -9.8211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3954 -10.2253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4010 -11.0425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0952 -12.0211 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3743 -7.7739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3799 -8.5910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6758 -9.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9660 -8.5997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9603 -7.7825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6645 -7.3696 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1485 -7.5140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1602 -8.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6365 -8.1715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0793 -10.1024 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5913 -9.4449 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0676 -8.7801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8478 -9.0254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5520 -8.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2618 -9.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2675 -9.8339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5633 -10.2468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8535 -9.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8298 -10.8826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
1 4 1 0
4 9 1 0
1 10 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
18 19 2 0
17 19 1 0
11 17 1 0
12 18 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
20 28 1 0
23 28 2 0
20 29 1 0
14 25 1 0
7 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.46Molecular Weight (Monoisotopic): 386.1855AlogP: 2.83#Rotatable Bonds: 2Polar Surface Area: 78.84Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.63CX LogP: 1.71CX LogD: 1.65Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -0.65
References 1. Hatcher JM, Vatsan PS, Wang E, Jiang J, Gray NS.. (2021) Development of Highly Potent and Selective Pyrazolopyridine Inhibitor of CDK8/19., 12 (11.0): [PMID:34795857 ] [10.1021/acsmedchemlett.1c00300 ]